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ABSTRACT
Ever increasing evidence has been provided on the
accumulation of mutations in the mitochondrial DNA
(mtDNA) during the aging process. However, the
lack of direct functional consequences of the
mutant mtDNA load on the mitochondria-dependent
cell metabolism has raised many questions on the
physiological importance of the age-related mtDNA
variations. In the present work, we have analyzed
the bioenergetic properties associated with the
age-related T414G mutation of the mtDNA control
region in transmitochondrial cybrids. The results
show that the T414G mutation does not cause per
se any detectable bioenergetic change. Moreover,
three mtDNA mutations clustered in the 16S riboso-
mal RNA gene cosegregated together with the
T414G in the same cybrid cell line. Two of them,
namely T1843C and A1940G, are novel and associ-
ate with a negative bioenergetic phenotype. The
results are discussed in the more general context
of the complex heterogeneity and the dramatic
instability of the mitochondrial genome during cell
culture of transmitochondrial cybrids.
INTRODUCTION
Human mitochondria are known as the power plants of
eukaryotic cells. To fulﬁl their main task, they utilize reduc-
tion equivalents in form of NADH and molecular oxygen
to generate an electrochemical potential across the inner
mitochondrial membrane that is in turn utilized to generate
ATP. Deﬁciencies in oxidative phosphorylation (OxPhoS)
activity ultimately lead to a decrease in oxidative energy
supply. Moreover, OxPhoS defects are accompanied by an
increase of reactive oxygen species. The reactive oxygen
species come into play when electrons in the initial steps
of the malfunctioning electron transport chain are trans-
ferred directly to molecular oxygen. The formed superoxide
anion (O2
 ) is converted by the mitochondrial superoxide
dismutase to hydrogen peroxide (H2O2) that can further
generateanumberofotherreactiveoxygen/nitrogenspecies,
thereby damaging membranes, proteins, RNA and DNA.
Ever increasing evidence has been accumulated in the
recent years on the role played by the mitochondria during
the aging process (1,2). In particular, attention has been
paid to the characterization and identiﬁcation of age-
associated mitochondrial DNA (mtDNA) mutations (3).
Rearrangements of mtDNA molecules have been usually
found at very low levels, thus questioning their functional
signiﬁcance (3). However, recent reports have demon-
strated that high levels of mtDNA deletions can be
detected in substantia nigra neurons in aging (4,5).
Moreover, the work of Michikawa et al. (6) showed that
speciﬁc single base replacements of mtDNA can accumu-
late during aging in human ﬁbroblasts and opened a
complete new aspect in this ﬁeld. This work was further
substantiated by animal models that focused on the prema-
ture aging in mice expressing defective mtDNA polymerase
gamma (7). Also in this case, the contribution of mtDNA
pointmutationstotheagingprocesshasbeenrecentlychal-
lenged (8). Therefore, the physiological importance of
mtDNA variations is still under intense debate (9).
The aim of the present work was to study the functional
impact of the age-related T414G mutation that is located
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inﬂuence of nuclear/mitochondrial genome background,
we have ﬁrst analyzed the biochemical phenotype of
homoplasmic transmitochondrial cybrids carrying either
the 414T (wild-type) or 414G (mutant) mtDNA genotype
deriving from the same heteroplasmic mitochondrial
donor(s) and nuclear acceptor cell lines. Our results
show that the T414G mutation does not cause per se
any detectable bioenergetic change. Unexpectedly, when
we checked the complete mtDNA sequence of the only
homoplasmic T414G cybrid (AL4.3) showing a negative
bioenergetic phenotype, we found three additional muta-
tions in the 16S rRNA gene. Two of these mutations were
responsible for a defective mitochondrial protein synthesis
eﬃciency.
The results are ﬁnally discussed in the larger context of
the suitability of the transmitochondrial cybrid system for
the characterization of the phenotypic impact of speciﬁc
mtDNA alterations.
MATERIALS AND METHODS
Cell linesand media
The AL4.3, AL4.5, 1AC1.2 human cell lines, carrying in
homoplasmic form the T414G transversion in the mtDNA
and the AL4.8, AL4.27 and 1AC1.48 cell lines, carrying in
homoplasmic form the wild-type version (T) of the same
position (414) of the mtDNA, were previously isolated by
transfer into human mtDNA-less 143B.TK
  r
0206 cells of
mitochondria from ﬁbroblasts of the individuals 100-3y
(for the AL series of transformants) and 98y (for the
1AC series of transformants) (6,10). All cell lines were
grown in DMEM, supplemented with 10% fetal bovine
serum (FBS). The r
0206 cell line was grown in DMEM
with 10% FBS and 50mg/ml uridine. For growth mea-
surements in selective galactose medium, cells were cul-
tured in DMEM lacking glucose and containing 0.9mg
of galactose/ml and 0.5mg of pyruvate/ml supplemented
with 10% dialyzed FBS.
Measurement ofrespiration rates inintact cells
The respiratory activity of intact cells was measured polar-
ographically with a Clark-type oxygen electrode in a
water-jacketed chamber (Hansatech Instruments, Nor-
folk, UK), magnetically stirred at 378C, as previously des-
cribed (11,12). Brieﬂy, exponentially growing cells, ﬂuid
changed the day before the measurement, were collected
by trypsinization and centrifugation, and then transferred
into the polarographic chamber at 3–4 10
6 cells/ml in
TD Buﬀer (0.137M NaCl, 5mM KCl, 0.7mM Na2
HPO4, 25mM Tris–HCl, pH 7.4), previously air equili-
brated at 378C. The resuspended cell samples were read
directly (basal endogenous respiration) and after addition
of 2,4-dinitrophenol (DNP) to 25–30mM (uncoupled
endogenous respiration) or of DNP, antimycin A
(20nM), TMPD (Fluka/Sigma-Aldrich Chemie GmbH,
Buchs SG, Switzerland) (0.4mM) and sodium ascorbate
(10mM) (cellular cytochrome oxidase respiratory
activity).
Determination of mitochondrial enzyme activities
Cells, collected by trypsinization and centrifugation, were
resuspended in buﬀer A (75mM sucrose, 5mM KH2PO4,
40mM KCl, 0.5mM EDTA, 3mM MgCl2, 30mM Tris–
HCl, pH 7.4), counted and supplemented with 15–20mg/
10
6 cells of digitonin. After 1–2min, the cell suspension
was further diluted by adding nine volumes of the same
buﬀer supplemented with 0.3% fatty-acid-free bovine
serum albumin and centrifuged; the pellet was then resus-
pended in hypotonicmedium (25mMpotassium phosphate,
pH 7.4, 5mM MgCl2), supplemented with antiproteases
cocktail (Roche Diagnostics, Mannheim, Germany). In
order to allow complete accessibility of substrates to the
inner mitochondrial membrane enzymes, samples were
freeze-thawed three times. All enzyme activities were mea-
sured at 308C using 0.1–0.3mg/ml of lysate proteins with
a Beckman DU7400 spectrophotometer equipped with a
rapid-mixing apparatus, as previously described (13).
NADH–CoQ oxidoreductase (Complex I) activity was
measured in hypotonic medium supplemented with fatty-
acid-free bovine serum albumin (BSA) (2.5mg/ml) in the
presence of 2mM KCN, antimycin A (2mg/ml) and 65mM
decylubiquinone, by following the rotenone-sensitive
initial rate of NADH (13mM) oxidation at 340–425nm
(e=6.81mM
 1cm
 1). Rotenone (2mg/ml) inhibited the
enzymatic activity by 85–95%.
Succinate dehydrogenase (Complex II) activity was mea-
sured in hypotonic medium in the presence of succinate
(20mM), rotenone (2mg/ml), antimycin (2mg/ml) and
2,6-dichlorophenolindophenol (50mM) by following the
reduction of 2,6-dichlorophenolindophenol at 600nm
(e=19.1mM
 1cm
 1). Prior to the measurement, pro-
teins were incubated for 10min in the hypotonic medium
in the presence of 20mM succinate. The reaction was
started with decylubiquinone (65mM). The sensitivity of
the reaction to the complex II inhibitor malonate
(20mM) was of 98%.
Succinate–cytochrome c oxidoreductase (complex II+
III) activity was measured at 550–540nm (e=
19.1mM
 1cm
 1) asinitial rateof antimycin-sensitive cyto-
chrome c reduction. As for complex II assay, a preincuba-
tion of proteins for 10min in the assaybuﬀer plus succinate
(20mM) was required. Rotenone (3mg/ml), 2mM KCN
and 65mM decylubiquinone were added to the assay
buﬀer andafter baselinerecording, the reactionwas started
by the addition of 20mM ferricytochrome c. The activity
was 90–95% inhibited by antimycin A (2mg/ml).
Cytochrome c oxidase (complex IV) activity was mea-
sured by following the oxidation of ferrocytochrome c
(20mM) at 550–540nm (e=19.1mM
 1cm
 1). Enzy-
matic activity was estimated in the assay buﬀer supplemen-
ted with 0.5mM dodecyl maltoside in the presence of
antimycin A (3mg/ml), as the apparent ﬁrst-order rate con-
stant after all cytochrome c oxidation induced by the addi-
tion of few grains of potassium hexacyanoferrate. This rate
was inhibited over 95% by KCN (2mM).
Citrate synthase activity, used as mitochondrial
matrix enzymatic marker, was measured in hypotonic
medium plus 0.3mM acetyl coenzyme A, and 0.2mM
5-50-dithio-bis 2-nitrobenzoic acid (DTNB) was added to
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Triton X-100. The reaction was started, after a 10min
preincubation, by the addition of 0.5mM oxalacetate
and the initial rate was measured following the reduction
of DTNB at 412–360nm (e=13.6mM
 1cm
 1).
Protein concentration was determined according to
Bradford method, using BSA as standard.
Westernblot analysis ofmitochondrial proteins
For western blots, equal amounts of total cellular proteins
(10–20mg) were separated on a 13% SDS–polyacrylamide
gel and transferred onto nitrocellulose membrane.
Membranes were then blocked with 5% nonfat milk in
0.1% TBS–Tween-20 and probed with speciﬁc antibodies
against mitochondrial-encoded subunit I (COXI gene,
Molecular Probes, Eugene, OR, USA) and 20kDa subunit
(MTND6 gene, Molecular Probes) and against nuclear-
encoded subunit IV (COXIV, Molecular Probes) and
39kDa subunit (NDUFA9 gene, Molecular Probes) of
respiratory complex I and complex IV, respectively.
Membranes were also probed with speciﬁc antibodies
against actin (from Sigma) utilized as loading control.
Membranes were ﬁnally incubated with HRP-conjugated
secondary antibodies and developed with a chemilumines-
cent reagent (NEN). The bands were quantiﬁed with a
VersaDoc 1000 Imaging System using the Quantity One
software (Bio-Rad Laboratories, Hercules, CA, USA).
Isolationof genomic DNA
Genomic DNA was isolated from cells by a proteinase K/
SDS treatment and phenol/chloroform extraction accord-
ing to standard procedures (14). Total DNA was extracted
from cell cultures by IsoQuick Nucleic Acid Extraction kit
(ORCA Research, Inc., Bothell, WA, USA) according to
manufacturer’s procedures.
PCR amplification and sequencing of themtDNA
Oligonucleotides used for PCR ampliﬁcation and mtDNA
sequencing were named and numbered according to the
original published human mtDNA sequence (15).
Extension of the number by -For or -Rev indicates the
50–30 direction of the oligonucleotide according to the pub-
lished sequence. In detail, the primer pairs 15501-For/
7608-Rev and 6203-For/16492-Rev were used to amplify
the entire human genome in two fragments using the Taq
Polymerase gold ampliﬁcation kit and protocol (Applied
Biosystems, Foster City, CA, USA). Sequencing of the
puriﬁed DNA fragments was carried out utilizing the
ABI BigDye Terminator sequencing kit in conjunction
with the ABI 310 DNA sequencer and the following pri-
mers: 534-For (nts 534–553); 679-Rev (nts 679–658); 1319-
For (nts 1319–1336); 1696-Rev (nts 1696–1677); 1749-For
(nts 1749–1765); 2162-For (nts 2162–2182); 2525-For
(nts 2525–2541); 3345-Rev (nts 3345–3325); 3654-For
(nts 3654–3674); 3717-Rev (nts 3717–3701); 4508-Rev
(nts 4508–4489); 4828-For (nts 4828–4847); 4966-Rev
(nts 4966–4951); 5312-For (nts 5312–5331); 5720-For
(nts 5720–5738); 5971-For (nts 5971–5988); 6203-For
(nts 6203–6224); 6301-For (nts 6301–6321); 6790-For
(nts 6790–6810); 7392-For (nts 7392–7411); 7608-Rev
(nts 7608–7588); 7707-For (nts 7707–7723); 8150-For
(nts 8150–8166); 8557-For (nts 8557–8574); 9026-For
(nts 9026–9042); 9500-For (nts 9500–9520); 9911-For
(nts 9911–9932); 10126-For (nts 10126–10146); 10712-
For (nts 10712–10728); 11141-For (nts 11141–11158);
11673-For (nts 11673–11692); 11979-For (nts 11979–
11995); 12376-For (nts 12376–12394); 12861-For (nts
12861–12877); 13197-For (nts 13197–13213); 13595-For
(nts 13595–13611); 14000-For (nts 14000–14023); 14407-
For (nts 14407–14424); 15243-For (nts 15243–15259);
15360-Rev (nts 15360–15343); 15501-For (nts 15501–
15522); 16162-Rev (nts 16162–16140); 16492-Rev (nts
16492–16471); 16493-For (nts 16493–16514); 16547-Rev
(nts 16547–16527)
T414G detection
Primers For1-20 and Rev690-711 ampliﬁed a 711-bp frag-
ment of the D-loop region. Ampliﬁcation parameters were:
5min at 948C for the ﬁrst cycle, denaturation at 948Cf o r
30s, annealing at 568C for 30s, extension at 728C for 45s
forthesubsequent 28cyclesandaﬁnalextensionat728Cfo r
10min. PCR products were analyzed by SfaNI digestion for
3h at 378C. All digested products were separated by elec-
trophoresis using a 2.5% agarose gel and visualized under
ultraviolet light after staining with ethidium bromide.
Identification andquantification of pointmutations
by mispairing PCR
To analyze the T1843C, A1940G and A2623G point
mutations in the 16S rRNA gene by mispairing PCR,
part of the mitochondrial ribosomal gene was ampliﬁed
by 1486-For (cccgtcaccctcctcaagtatacttca) and 3015-Rev
(ccatcgggatgtcctgatccaaca). The ampliﬁed fragment
served as target for the nested ampliﬁcations with the fol-
lowing primer sets. Characterizations of nucleotides 1843
and 1940 were carried out by nested ampliﬁcation utilizing
the primer combinations wt/mut1819-For and wtA1960-
Rev, wt/mut1819-For and mutG1960-Rev; analysis of
position 2623 was realized by amplifying fragments utiliz-
ing the primer combinations 2559-For and wtA2650-Rev
and 2559-For and mutG2650-Rev.
The following primers were utilized during mispairing
PCR ampliﬁcation (bold nucleotides indicate modiﬁed
nucleotides that introduce a partial cleavage sequence
that is completed either by the following wild-type or
mutant sequence):
wt/mut1819-For: (aagcataatatagcaaggactaacccGta)
wtA1960-Rev: (actattttgctacatagacgggtgAgc)
mutG1960-Rev: (actattttgctacatagacgggtgGgc)
2559-For: (catgttcggccgcggtaccctaa)
wtA2650-Rev: (aaccctcgtggagccattcatacCgg)
mutG2650-Rev: (aaccctcgtggagccattcatacGgg)
Analysis of position 1843 was carried out by cleaving the
ampliﬁed fragment either with XmiI (cleaves the mispair-
ing PCR-modiﬁed wild-type mtDNA) or RsaI (cleaves the
mispairing PCR-modiﬁed mutated mtDNA).
Characterization of position 1940 was performed by cleav-
ing the ampliﬁed fragment by SacI (cleaves the mispairing
PCR-modiﬁed wild-type mtDNA) or Bsp120I (cleaves the
mispairing PCR-modiﬁed mutant mtDNA). Position 2623
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either with BshTI (cleaves the mispairing PCR-modiﬁed
wild-type mtDNA) or Bsp120I (cleaves the mispairing
PCR-modiﬁed mutant mtDNA). The cleaved products
were visualized by ethidium bromide staining.
The images shown in this article are ethidium bromide
stains that do not necessarily display accurately the quan-
titative yields.
Cloning and sequencing
Primers corresponding to nucleotide positions (nt, 50–30,
according to Cambridge sequence (15)) For1549–1570
and Rev3359–3380 ampliﬁed a 1831-bp coding region
spanning the entire MT-RNR2 gene. All PCR fragments
were obtained with the Platinum TAQ DNA Polymerase
High Fidelity. Ampliﬁcation parameters were: 2min at
958C for the ﬁrst cycle, denaturation at 948C for 30s,
annealing at 558C for 30s, extension at 688C for 2min
for the subsequent 27 cycles and a ﬁnal extension at 728C
for 10min. PCR fragments were subcloned into a suitable
plasmid using TOPO TA cloning kit (Invitrogen, Carlsbad,
CA, USA); several independent clones were analyzed, ran-
domly isolated from each single PCR fragment. Cloned
mtDNA molecules were used as template in a second
round of PCR using commercial primers T3 and T7.
PCR products were puriﬁed using ExoSAP-IT treatment
(Amersham Biosciences, Buckinghamshire, UK) and dis-
pensed in 96-well plates for sequencing with an automated
sequencer 3100 (Applied Biosystem) and analyzed with
SeqScape Sequence Analysis software. The mutational
burden for a given sample was calculated as the number
of mutations (deﬁned as discrepancies with the Cambridge
reference sequence) found in multiple clones divided by
the total number of sequenced bases.
Graphical representation of human mitochondrial
LSU RNA
The secondary structure model of human mitochondrial
16S rRNA was derived from entry V00710 of the riboso-
mal database (16) with Escherichia coli 23S rRNA as a
template and visualized with RnaViz2 (17). The structure
was manually reﬁned and some minor changes were
included in the H2 and H4 helices. Numbering of 16S
rRNA nucleotides and helical regions is according to the
database alignment; structural domains are indicated by
roman numbering.
Statistical analysis
Data are expressed as means   SD and were statistically
analyzed utilizing the Student’s t-test.
RESULTS
Cybrid cell lines derived from fusion experiments
that were carried out between 143B.r
0 cells [prepared
as described earlier by King and Attardi (18)] and enu-
cleated ﬁbroblasts from a 100-year-old donor. The cell
lines were described earlier by Michikawa et al. (10).
In particular, the AL4.8 and AL4.27 are homoplasmic
wild-type at position 414 of the human mitochondrial
genome, whereas the AL4.3 and AL4.5 carried the age-
associated T414G transversion at a homoplasmic level.
Preliminary screening of the bioenergetic competence of
the cell clones was carried out by their ability to grow on
galactose selective medium (Table 1). It turned out that all
cell lines were capable of growing on galactose, besides
clone AL4.3 (mut). This was conﬁrmed by the analysis
of the endogenous respiratory ﬂuxes measured in intact
cells. In fact, it is shown in Table 1 that the basal and
the maximal dinitrophenol uncoupled respiration rates
of the AL4.3 cells were signiﬁcantly lower as compared
with all the other cell lines. No signiﬁcant diﬀerences
were observed among all other cell lines. Surprisingly,
even the homoplasmic mutant AL4.5 cells, although
coming from the same mitochondrial donor, displayed
full bioenergetic competence. Furthermore, we also exam-
ined an additional homoplasmic mutant T414G cybrid cell
line (AC1.2) that was derived from a diﬀerent mitochon-
drial donor (age of 98 years) and also showed full bioener-
getic competence. This led us to the conclusion that the
T414G mutation is not per se responsible for the dimin-
ished respiration rate.
In order to identify the enzymatic defect possibly asso-
ciated with the respiratory deﬁciencies of the AL4.3 cell
line, the enzyme activities of the mitochondrial respiratory
complexes were measured spectrophotometrically.
As shown in Table 2, the AL4.8 (wt) cell line does not
show any signiﬁcant diﬀerence with the parental cell line
143B.TK
 . On the other hand, complex I, complex
II+III and complex IV activities of the AL4.3 cell line
were decreased by 81, 55 and 62%, respectively, as com-
pared with the AL4.8 cell line. However, complex II activ-
ity is not being aﬀected in the AL4.3 cell line.
The above diﬀerences were conﬁrmed when normalizing
the enzyme activities of the respiratory complexes to mito-
chondrial matrix marker citrate synthase (data not
shown). No signiﬁcant diﬀerence was found when analyz-
ing AL4.5 cells (data not shown), thus conﬁrming no
direct linkage between the T414G mutation and the
respiratory defects found in the AL4.3 cell line.
Nevertheless, the speciﬁc decline of the mitochondrial
complexes I, II+III and IV that do contain
Table 1. Mitochondrial bioenergetic competence of 143B. TK
  and
transmitochondrial cell lines
Cell Line
(genotype)
Growth in
galactose
Endogenous
respiration
[nmol O2/min/mgprot.]
DNP-uncoupled
respiration [nmol
O2/min/mgprot.]
143B.TK
  (414T) + 9.9 0.4 16.8 2.0
AL4.8 (414T) + 8.7 1.0 14.2 2.3
AL4.27 (414T) + 9.1 1.1 14.9 0.6
AL4.3 (T414G)   2.5 0.3  3.4 0.6  
AL4.5 (T414G) + 9.7 1.1 15.4 1.7
The transmitochondrial cell lines derived from fusion experiments
between a 100 year-old ﬁbroblast donor and mtDNA-less acceptor
cell-line (143B.TK
 r206). Cells were tested for their ability (+/ )t o
grow on galactose selective medium. The values of the respiration rates
represent the mean values SD from 2–4 independent experiments.
 P<0.01 and   P<0.05; AL4.3 versus AL4.8 (see Materials and meth-
ods section for experimental details).
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defect in the nuclear encoded complex II, pinpoints to the
possibility of the existence of other yet unknown mtDNA
variants in the AL4.3 cell line.
This led us to sequence the entire mitochondrial genome
of the AL4.8 and AL4.3 cybrid cell lines. Apart from the
diﬀerence at position 414 (T in the AL4.8 and G in
AL4.3), 21 homoplasmic single base replacements were
detected in both cell lines when compared to the Sanger
sequence (15). Three mutations were located in the
D-loop, one in the 12S ribosomal RNA gene and 17 in
protein coding regions (see Supplementary Material I for a
detailed list of the mitochondrial genotype).
Surprisingly, the AL4.3 cells displayed three additional
heteroplasmic mutations all clustered within the16S rRNA
gene, namely T1843C, A1940G and A2623G (Figure 1).
These mutations were neither detectable in the AL4.8 cell
line (Figure 1), the AL4.5 and the AL4.27 cell line, nor
in the original DNA extract of the donor ﬁbroblasts
(data not shown). Interestingly, the A2623G mutation
cosegregated in homoplasmic form together with the
T414G mutation in the above mentioned cybrid (AC1.2)
deriving from a diﬀerent mitochondrial donor. Also, in
this case, the bioenergetic competence of the AC1.2 cell
line excluded a direct impact of the A2623G mutation on
the mitochondrial functionality.
To quantify the heteroplasmic states of the 16S rRNA
mutations, we decided to develop a mispairing PCR test.
In this context, a partial region of the 16S rRNA gene was
ampliﬁed that encompassed the positions of all three point
mutations (see Materials and methods section for details).
The ampliﬁed product served as target for nested PCRs,
so that upon RFLP analysis, mutated and wild-type
mtDNA could be distinguished by gel electrophoresis
(Figure 2) and quantiﬁed accordingly. The heteroplasmic
mutation levels obtained as the mean value of the quanti-
ﬁcation of the cleaved fragments were of 54, 64 and 54%
for the T1843C, A1940G and A2623G, respectively. These
values were in agreement with the relative values of
the wild-type and mutant peaks of the electropherograms
displayed in Figure 1.
Due to the limitations of the direct sequencing (sec-
ondary DNA structure), as well as of the mispairing
PCR approach (‘heteroduplex formation’) and RFLP ana-
lysis (partial enzyme cleavage) in quantifying heteroplas-
mic mtDNA mutations, we decided to apply the same
cloning and sequencing technique originally used for the
T414G mutations (6). This technique additionally allowed
us to position the three mutations on the mitochondrial
DNA at a molecular level. As shown in Table 3, the
T1843C and A1940G showed a striking cosegregation as
opposed to the A2623G mutation thus accounting for at
least three distinct mitochondrial genome types just in
relation to the three above mentioned 16S rRNA muta-
tions. On 36 analyzed, genetically independent clones,
61% carried both the T1843C and A1940G mutations,
while 33% carried only the A2623G mutation. One
clone carried only wild-type DNA in respect to 1843,
1940 and 2623, while another one carried only the
A1940G mutation. A similar analysis was carried out on
AL4.8 DNA and conﬁrmed exclusively wild-type sequence
at positions 1843, 1940 and 2623 (data not shown).
Additionally, a similar amount of randomly distributed
point mutations was found at a low percentage (1–2/36
clones) within the analyzed fragment in both the AL4.8
and AL4.3 cybrids, with the exception of T1975C (3/36
clones) in the AL4.3 DNA (see Supplementary Material II
for a detailed genotype list of the 16S rRNA containing
clones).
To distinguish which of the three 16S rRNA mutations
may account for the bioenergetic deﬁciencies observed in
Table 2. Enzyme activity of mitochondrial respiratory complexes from
143B.TK
 , AL4.8 and AL4.3 cybrid cells
Cell line I II II + III IV
143B.TK
 
[nmoles/mg/min]
14.5 23 46.2 11.8 33.0 9.8 24.7 7.4
AL4.8 [% of 143B.TK
 ] 113 48 117 34 119 44 116 52
AL4.3 [% of AL4.8] 21 4  104 13 53 22  44 19 
The values represent the mean values   SD from 3–9 independent
experiments. The enzyme activities of the parental 143B cell line are
expressed as nanomoles per milligram per minute. The enzyme activ-
ities of the AL4.8 and AL4.3 cybrid cell lines are expressed as percen-
tage values of the 143B and AL4.8 cell lines, respectively.  P<0.0001;
AL4.3 versus AL4.8 (see Materials and methods section for experimen-
tal details).
Figure 1. Sequence analyses of the mitochondrial 16S rRNA genes. Displayed are the electropherograms related to the 1843, 1940 and 2623 positions
in the 16S rRNA genes of the AL4.8 and AL4.3 cells. The shaded areas highlight the homoplasmic and heteroplasmic peaks of wild-type and
mutated mtDNAs, respectively.
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AL4.3 cell line upon selective growth conditions. When
cells were selected on galactose medium under otherwise
identical conditions (Table 4), interestingly the T1843C
and A1940G levels were selectively diminished (50 and
44%, respectively), while A2623G level increased up to
47%. These results conﬁrmed the T1843C and A1940G
mutations as those most likely being responsible of the
mitochondrial defects. Interestingly, the T1975C mutation
level was also increased after galactose selection (5/36
clones).
In the light of the clustered appearance of the three
mutations in the 16S rRNA gene, we measured the protein
expression of mitochondrial- and nuclear-encoded subu-
nits of respiratory complex I and complex IV. As shown in
Figure 3, the protein level of nuclear-encoded subunit IV
and 39kDa subunit of complex IV and complex I, respec-
tively, was similar in AL4.8 and AL4.3 total cell lysates.
On the other hand, the level of the mitochondrial-encoded
catalytic subunit I of respiratory complex IV of AL4.3 cells
Figure 2. Mispairing PCR and RFLP analyses of heteroplasmic point
mutations in the mitochondrial 16S rRNA gene. The 1843, 1940 and
2623 positions were analyzed by RFLP analyses as described under
Materials and methods section. XmiI, SacI and BshTI restriction
enzymes were used to cleave the mispairing PCR products carrying
the wild-type genotype at positions 1843, 1940 and 2623, respectively
(upper panels). RsaI and Bsp120I restriction enzymes were used to
cleave the mispairing PCR products carrying the mutant genotype at
positions 1843 and 1940 or 2623, respectively (lower panels). The dis-
played ethidium bromide stained gels (upper and lower panels) refer to
representative experiments.
Table 3. Analyses of the 16S rRNA gene mutations by
cloning-sequencing approach in AL4.3 cells
AL4.3 Mitochondrial genotypes
T1843C A1940G A2623G
1+
2+ +
3+ +
4+ +
5+ +
6+ +
7+ +
8+
9+
10
11 + +
12 + +
13 +
14 +
15 + +
16 +
17 + +
18 + +
19 + +
20 + +
21 + +
22 +
23 +
24 + +
25 + +
26 +
27 +
28 + +
29 + +
30 +
31 +
32 + +
33 + +
34 + +
35 +
36 + +
The 36 E. coli clones carried the mtDNA fragment encompassing
nucleotides 1671–3228 of the 16S rRNA gene derived from AL4.3
cells (see Materials and methods Section as well Supplementary
Material II for further details and complete sequences).
Table 4. Analyses of the 16S rRNA gene mutations by
cloning-sequencing approach in galactose selected AL4.3 cells
AL4.3 Mitochondrial genotypes
Gal–select T1843C A1940G A2623G
1+
2+ +
3
4+ +
5+
6+ +
7+
8+
9+
10 +
11 +
12 +
13 + +
14 +
15 +
16 +
17 + +
18 + +
19 + +
20 + +
21 +
22 +
23 +
24 + +
25 +
26 +
27 + +
28 + +
29 + +
30 + +
31 +
32 + +
33 +
34 +
35 + +
36 + +
The 36 E. coli clones carried the mtDNA fragment encompassing
nucleotides 1671–3228 of the 16S rRNA gene derived from galactose-
selected AL4.3 cells (see Materials and methods section as well Supple-
mentary Material II for further details and complete sequences).
Nucleic Acids Research, 2008, Vol. 36, No. 18 5877was signiﬁcantly reduced by 43% as compared with AL4.8
cells, with this change being in good agreement with
the above described reduction in complex IV activity
(Table 2). Furthermore, the mitochondrial-encoded
20kDa subunit of respiratory complex I was barely detect-
able in AL4.3 cells. These results conﬁrmed the direct and
speciﬁc impact of the 16S rRNA mutations on mitochon-
drial protein synthesis machinery.
DISCUSSION
The open controversy about a possible involvement of
mtDNA variations in the aging process makes it neces-
sary to associate functional data to genetic association
studies. The discovery of the age-associated accumulation
of the T414G mutation in human ﬁbroblast mtDNA in
1999 (6) shifted the attention from simple DNA rear-
rangements to the more complex single and multiple
base replacements. Consequently, the tissue speciﬁcity of
certain point mutations was genetically linked to the
general aging process (19) as well as to age-associated
neurodegenerative disorders (20). Some of these mutations
have been shown to aﬀect mtDNA transcription and/or
replication (20,21), but their impact on the bioenergetic
functionality of mitochondria has not yet been investi-
gated. Furthermore, the simultaneous occurrence of dif-
ferent mutations makes it diﬃcult to assign speciﬁc eﬀects
to single mutations, while giving more importance to their
synergy hence to the mitochondrial haplotype (22,23).
Even the earliest developmental processes seem to attri-
bute certain aspects of aging, since the T414G trans-
version accumulates in an age-dependent manner in
human oocytes (24).
Cybrid cell lines have long been used in the analysis of
mutant mtDNA on a neutral nuclear background so that
biochemical and enzymatic analysis could be carried out.
The rationale behind the use of the transmitochondrial cell
lines was mainly based on the assumption that in these
cells the possibility of diﬀerently expressed nuclear
isoforms as well as the impact of diﬀerent nuclear haplo-
types on the overall cellular phenotype should have been
avoided. Therefore, we have utilized transmitochondrial
cybrids generated by the fusion of cytoplasts from aged
individuals with mtDNA-depleted 143B.TK
  (r
0 cells),
thus carrying either the 414T (wild-type) or 414G
(mutant) mtDNA genotype. The ﬁrst outcome of this ana-
lysis excludes a direct impact of the T414G mutation onto
the mitochondrial bioenergetic eﬃciency and capacity. In
fact, two cybrid cell lines homoplasmic for the T414G
mutation showed a full bioenergetic competence.
However, the existence of a third homoplasmic T414G
cybrid cell line presenting with a deﬁcient bioenergetic
phenotype strongly suggested the possibility of additional
mtDNA variants. Indeed, we found three additional ribo-
somal RNA mutations, two of which, i.e. T1843C and
A1940G were recorded for the ﬁrst time at MitoMap data-
base (25). The third mutation (A2623G) was previously
reported as to be a polymorphic site (26) although it was
not functionally characterized. Our results clearly rule out
the A2623G mutation produces any detectable bioener-
getic defect since the coexistence of this mutation at a
homoplasmic level together with the T414G mutation
has been found in a fully respiratory competent transmi-
tochondrial cybrid cell line. This conclusion is strength-
ened by the ﬁnding that the heteroplasmic level of this
mutation in galactose selected cells is increased.
Our results lead us to propose that the T1843C and the
A1940G mutations are the cause of the observed bioener-
getic deﬁciency. The underlying molecular mechanism is
most likely linked to the malfunctioning translational
system of mitochondria, since the 16S rRNA is an integral
member of the mitochondrial protein synthesis machinery.
As shown in Figure 4, the mutations relevant for the
bioenergetic deﬁciency are not located in close proximity
to the catalytic center of the rRNA, which is mainly
formed by the central loop of domain VI (27). Instead,
they are located in the 50 part of the RNA. The role of
the A1940G mutation (A270G in the RNA) is readily
explained, because the change leads to formation of a
G U wobble pair instead of a regular A–U base pair,
and thus will destabilize helix D8 in domain II.
Although this helix is not directly linked to the catalytic
region, a tertiary interaction between A323 in Loop D10
to C767 in the E16–E4 junction (green line in Figure 4)
will bring this whole structure in close proximity to the
peptidyl transferase center and may thus inﬂuence the
overall stability of this domain.
The defect caused by the T1843C mutation (U173C in
the RNA) is not as straightforward to explain, because
domain I in mitochondrial 16S rRNA is much less struc-
tured than the corresponding part of bacterial 23S rRNA.
Whereas the latter is forming a highly ordered stem-loop
arrangement and is linked to the 30- end of the RNA by
a regular helical stem, only some small isolated stem-loop
structures are present in the mitochondrial RNA, and no
extended pairing to the 30-end is possible. Even a manual
search for alternative secondary structures in the region
did not reveal any possible structural stabilization within
this region close to the 50-end of 16S rRNA.
Figure 3. Expression level of nuclear- and mitochondrial-encoded sub-
units of respiratory complex I and complex IV. Nuclear- (nuc) and
mitochondrial- (mit)encoded complex I and complex IV subunit levels
in AL4.3 cells (white bars) were normalized to actin and expressed as
percent of the AL4.8 control cells (black bars=100%). The western
blot analysis was carried out on total cell lysates. The values represent
the average of four independent determinations SD.
5878 Nucleic Acids Research, 2008, Vol. 36, No. 18Figure 4. Predicted secondary structure of the mitochondrial 16S rRNA. The nucleotides in the peptidyl transferase region (the multi-branched loop
connecting helices G1–G2–G16–G17), which are relevant for catalytic activity or chloramphenicol binding in bacterial 23S rRNAs are highlighted in
red. The mutations in mitochondrial 16S rRNA are also highlighted in red and their position within the rRNA is additionally indicated by red
numbers. Base numbering is according to the Ribosomal Database: position 173 corresponds to T1843C; position 270 to A1940G, and position 953
to A2623G, respectively. The long-range interaction between C767 and A323 is depicted by a thin green line. For clarity, base and helix numbering is
not contiguous.
Nucleic Acids Research, 2008, Vol. 36, No. 18 5879However, an eﬀect on mitochondrial 16S rRNA mod-
iﬁcation, stability and/or folding as well as an eﬀect on
ribosome assembly due to the interaction of nucleic
acid and protein subunits needs to be investigated. The
functional eﬀect of the mutations on mitochondrial trans-
lation is clearly demonstrated by the speciﬁc decline
of mitochondrial-encoded subunits of respiratory complex
I and IV observed by western blot analysis on total cell
lysates of AL4.3 cells, when compared to AL4.8 control
cells.
As stressed elsewhere (28), the coexistence of diﬀerent
mutations in the same gene makes it diﬃcult to assign a
speciﬁc function to each position unless clones carrying
only one of these mutations can be selected, as in the
case of the A2623G mutation in our study.
The discovery of three clustered mutations in the 16S
rRNA gene cosegregating together with the T414G muta-
tion oﬀered us the possibility both to investigate the phe-
notypic eﬀect of novel mtDNA variants as well as to
suggest a diﬀerent mechanism by which the age-associated
T414G mutation could lead to the accumulation of
additional mtDNA mutations (generator for mtDNA
alterations).
The striking observation that the T1843C and the
A1940G mutation appeared at a heteroplasmic state
may account for their recent occurrence in relation to
the homoplasmic presence of the T414G mutation. Even
more, the cloning and sequencing data clearly show that
T1843C and the A1940G appear on the same DNA mole-
cules as opposed to the A2623G mutation. If mutations in
the ribosomal gene region alter the looping mechanism
shown to occur during rRNA transcription (29), the eﬃ-
ciency of the mtDNA replication cycle could be aﬀected as
well. This could possibly explain the recently reported
linkage between a common photoaging-associated
mtDNA deletion and the T414G mutation (30).
Overall, this highlights the complex heterogeneity and
the dramatic instability of the mitochondrial genome
during tissue culture conditions (23). This is worsened
by the high variability of the osteosarcoma karyotype of
the 143B.TK
  acceptor cell line (P.S., unpublished data).
The present observation also underlines the need of a
continuous monitoring of mtDNA ﬁdelity when utilizing
transmitochondial cybrids, especially if patient’s diagnos-
tics has to rely exclusively on results obtained by this valu-
able and so far irreplaceable technique.
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